<DOC>
	<DOC>NCT01415518</DOC>
	<brief_summary>Efficacy and tolerability study in severe chronic obstructive pulmonary disease (COPD) patients.</brief_summary>
	<brief_title>Efficacy and Tolerability Study in Severe Chronic Obstructive Pulmonary Disease (COPD) Patients</brief_title>
	<detailed_description>Efficacy and tolerability study of Symbicort Turbuhaler (160/4.5µg/inhalation,2inhalations twice daily) added to Atrovent (20µg/inhalation, 2 inhalations 4 times daily) + theophylline SR(0.1g/tablet, 1 tablet p.o. twice daily) compared with Atrovent + theophylline SR in severe COPD patients.</detailed_description>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Signed and dated informed consent Men or women patients ≥ 40 years of age Diagnosis of COPD with symptoms for more than 2 years and there is a history of at least one COPD exacerbation requiring a course of oral steroids and/or antibiotics within 112 months before Visit 2 Forced Expiratory Volume in 1 second (FEV1) ≤50% of predicted normal value, prebronchodilator and Forced Expiratory Volume in 1 second (FEV1) / Forced Vital Capacity (FVC) &lt; 70%, prebronchodilator Total symptom score of 2 or more per day for at least half of runin period (breathing, cough and sputum scores from the diary card) and complete morning recordings of Digital Peak Flow Meter data at least 7 out of the last 10 days of the runin period A history of asthma and seasonal allergic rhinitis before 40 years of age Patients who have experienced exacerbation of COPD requiring hospitalisation and /or emergency room treatment and/or a course of oral steroids and/or intravenous corticosteroids and/or antibiotics within 4 weeks prior to Visit 2 and/or during runin period Patients with relevant cardiovascular disorder judged by the investigator Patients with glaucoma, prostatic hyperplasia or bladderneck obstruction judged by the investigator Women who are pregnant, breastfeeding or of childbearing potential judged by the investigator</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Severe chronic obstructive pulmonary disease (COPD) patients</keyword>
</DOC>